TrialHaematologica2016

Nilotinib 300 mg twice daily: an academic single-arm study of newly diagnosed chronic phase chronic myeloid leukemia patients.

Fausto Castagnetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.